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A Mendelian randomization approach
Seif O. Shaheen, PhD,a Clare Rutterford, MSc,a Luisa Zuccolo, PhD,b,c Susan M. Ring, PhD,b George Davey Smith, MD,b,c
John W. Holloway, PhD,d and A. John Henderson, MDb London, Bristol, and Southampton, United KingdomBackground: Alcohol consumption in western pregnant women
is not uncommon and could be a risk factor for childhood atopic
disease. However, reported alcohol intake may be unreliable,
and associations are likely to be confounded.
Objective: We aimed to study the relation between prenatal
alcohol exposure and atopic phenotypes in a large population-
based birth cohort with the use of a Mendelian randomization
approach to minimize bias and confounding.
Methods: Inwhitemothers and children in theAvonLongitudinal
Study of Parents and Children (ALSPAC) we first analyzed
associations between reported maternal alcohol consumption
during pregnancy and atopic outcomes in the offspringmeasured
at 7 years of age (asthma, wheezing, hay fever, eczema, atopy, and
total IgE). We then analyzed the relation of maternal alcohol
dehydrogenase (ADH)1B genotype (rs1229984) with these
outcomes (the A allele is associated with faster metabolism and
reduced alcohol consumption and, among drinkers, would be
expected to reduce fetal exposure to ethanol).
Results: After controlling for confounders, reported maternal
drinking in late pregnancy was negatively associated with
childhood asthma and hay fever (adjusted odds ratio [OR] per
category increase in intake: 0.91 [95% CI, 0.82-1.01] and 0.87
[95% CI, 0.78-0.98], respectively). However, maternal ADH1B
genotype was not associated with asthma comparing carriers of
A allele with persons homozygous for G allele (OR, 0.98 [95%
CI, 0.66-1.47]) or hay fever (OR, 1.11 [95% CI, 0.71-1.72]), nor
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Experiments in animals have shown that short-term alcohol
exposure inhibits TH1 responses and increases TH2 cytokine re-
sponses and IgE,1,2 although longer-term consumption has been
shown to reduce airway hyperresponsiveness and allergic inflam-
mation in an adult mouse model.3 In addition, prenatal exposure
can impair fetal lung growth and development,4-6 through in-
creased oxidative stress.7 In humans, reported alcohol intake is
positively associated with total IgE cross-sectionally, although as-
sociations with allergen-specific sensitization have been inconsis-
tent.8-10 Studies from Denmark have found that reported alcohol
consumption in pregnancy was positively associated with total
IgE in cord blood11 and postnatal atopic dermatitis12,13 but not
with hospitalization for asthma in childhood.14 Given these
data, and that the prevalence of low-to-moderate alcohol con-
sumption during pregnancy is high (30%-59%) in the United
Kingdom, Denmark, Sweden, Australia, and the United
States,15-20 it would seem important to establish whether prenatal
alcohol exposure might be contributing to the high prevalence of
childhood atopic disease in the west.21
One difficulty with using reported alcohol intake in pregnancy
to measure exposure is that underreporting of consumption is
common22 and, as with all observational studies, associations
may arise spuriously through bias, or because of unmeasured or
residual confounding, a particular problem in nutritional epidemi-
ology.23 Randomized trials of alcohol exposure in pregnancy
would be unethical, and we are not aware of any trials of alcohol
avoidance in pregnancy which have evaluated childhood atopic
outcomes. However, causal inference can be strengthened in
observational studies with the use of Mendelian randomization
to reduce measurement error and to minimize bias and confound-
ing.24,25 This approach hinges on the principle that genotype is
randomly allocated during meiosis, and consequently associa-
tions between genetic variants and disease are not generally sus-
ceptible to confounding by lifestyle factors. In addition, variants
should not be associated with the disease outcome of interest
except through their link to the modifiable risk process of interest.
In the case of alcohol, a nonsynonymous variant in the alcohol
metabolizing gene, alcohol dehydrogenase (ADH)1B, is thought
to accelerate ethanol clearance and to inhibit heavy drinking26
and can be used as a proxy for alcohol consumption. The
A allele is associated with faster conversion of alcohol to acetal-
dehyde, and this leads to reduced alcohol consumption. In Euro-
pean populations, this ADH1B variant is associated with
aerodigestive cancers,27 thus providing convincing evidence
that alcohol causes these conditions. Furthermore, in the Avon225
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(ALSPAC)GWAS: Genome Wide Association StudyPCA: Principal Components AnalysisLongitudinal Study of Parents and Children (ALSPAC), a United
Kingdom population-based birth cohort, the maternal ADH1B
gene variant was strongly associated with alcohol use before
and during pregnancy, suggesting that it could be used as a reli-
able instrument to study the consequences of prenatal (and peri-
conceptional) alcohol exposure.28 Indeed, to study the relation
between fetal alcohol exposure and cognitive development, we re-
cently used a Mendelian randomization approach in ALSPAC to
determinewhether genetic variants in alcohol metabolizing genes
were associated with childhood IQ.29
In ALSPAC, we have first analyzed whether reported alcohol
intake by mothers in pregnancy is associated with risk of atopic
disease in the offspring and then examined the relation between
the maternal ADH1B gene variant and these outcomes.METHODS
Subjects
ALSPAC is a population-based birth cohort that recruited 14,541 predom-
inantly white pregnant women resident in the Bristol area of the United
Kingdom during 1990 to 1992. There were 14,062 live born children, and
13,988 of these children were alive at 1 year of age and subsequently were
followed up. The cohort has been followed since birth with annual question-
naires and, since 7 years of age, with objective measures in annual research
clinics. The study protocol has been described previously,30,31 and further in-
formation can be found at http://www.alspac.bris.ac.uk. Ethics approval for all
aspects of data collection was obtained from the ALSPAC Ethics and Law
Committee (IRB 00003312) and the Local Research Ethics Committees.Exposures
Mothers were asked 8 weeks into their pregnancy to report their current
alcohol consumption (how many measures of beer, wine, spirit, or other
alcoholic drinks per day onweekdays andweekends), fromwhich the total units/
week were derived and then grouped to avoid categories with small numbers
(never, 1-2 units/week, 3-4 units/week, >_5 units/week). At 18 weeks of gestation
mothers were asked to recall their alcohol consumption just before the current
pregnancy (derived categories: never, <1 unit/week, 1-6 units/week, >_7 units/
week) and in the first 3months of pregnancy (never, <1 unit/week,>1unit/week).
(Asking about drinking habits just before pregnancy is likely to capture intake in
early gestation, before mothers have realized that they have conceived and had a
chance to alter their drinking behavior). At 8 weeks after delivery mothers were
asked to report their consumption in the last 2 months of pregnancy (never,
<1 unit/week, >1 unit/week).We alsodefinedmothers as ‘‘binge’’drinkers if they
reported drinking at least 4 units on 1 or more days (never, 1-2 days, >_3 days) in
the previous month when asked at 18 weeks of gestation.28Outcomes
When the children were 7.5 years old, mothers were asked, ‘‘Has your child
had any of the following in the past 12months: wheezing, asthma, eczema, hay
fever?’’ Children were defined as having current doctor-diagnosed asthma at
7.5 years (primary outcome of interest) if mothers responded positively to the
question, ‘‘Has a doctor ever actually said that your study child has asthma?’’
and positively to 1 or both of the questions on wheezing and asthma in the past
12 months.Atopy at 7 years was defined as a positive reaction (any detectable weal) to
Dermatophagoides pteronyssinus, cat, or grass (after subtracting positive sa-
line reactions from histamine and allergen wheals, and excluding children un-
reactive to 1% histamine). (Atopy defined in this way identified 96% of
children sensitized to 26 other allergens in this cohort.32) Serum total IgE
(in kU/L) was measured by fluoroimmunoassay with the Pharmacia UNICAP
system (Pharmacia & Upjohn Diagnostics AB, Uppsala, Sweden).Confounders
In multivariate analyses we controlled for the following potential con-
founders: maternal factors during pregnancy (smoking, infections, anxiety
score, antibiotic use, and paracetamol use); other maternal factors (educa-
tional level; housing tenure; financial difficulties; body mass index; age;
parity; history of asthma, eczema, rhinoconjunctivitis, migraine); sex of child,
season of birth, multiple pregnancy, gestational age, birth weight, head
circumference, birth length; postnatal factors (breast-feeding, day care, pets,
damp/mold, environmental tobacco smoke exposure, antibiotic and paracet-
amol use in infancy, number of younger siblings, body mass index at age 7).Genotyping
The majority of maternal DNA samples were extracted from whole blood
and white cells taken during pregnancy, and a minority were buccal DNA
extracted from mouthwash samples. A single nucleotide polymorphism
(rs1229984 in ADH1B) was typed by KBiosciences Ltd (Hoddesdon, Herts,
United Kingdom; www.kbioscience.co.uk) with a competitive allele-specific
PCR system (KASPar). The genotype distribution was compatible with no de-
parture from Hardy-Weinberg equilibrium, and the genotyping success rate
was >93.3% and error rate <0.25%.28Statistical analyses
Although theALSPACpopulation is largelywhite, we adopted 2 strategies to
reduce the possibility of confounding by population substructure, because the
rs1229984 variant is highly ethnically stratified. First, mother-child pairs were
excluded from all analyses if the mother’s reported ethnicity was non-white or
unknown. Second, to address possible residual confounding by population
substructure, we controlled for 10 variables derived by principal components
analysis (PCA) from ALSPAC genome-wide association study (GWAS) data.
We used logistic regression to analyze relations of maternal ADH1B
genotype with binary outcomes and linear regression to analyze associations
with log-transformed total IgE. Analyses of reported alcohol intake in
pregnancy were performed before and after controlling for confounders; tests
for trend were performed by analyzing reported alcohol exposure associations
as linear per category effects. In view of the rarity of the homozygous mutant
genotype (A:A), persons with this genotype were grouped together with
heterozygotes (G:A), and we assumed a dominant effect for analysis. Previous
analyses of this single nucleotide polymorphism inALSPACmothers in relation
to alcohol intake suggested that thiswas appropriate.28We also performed a pri-
ori stratifiedanalyses to explore potential interactions betweenmaternalADH1B
genotype and reported alcohol intake in pregnancy. All analyseswere performed
with Stata version 10.1 (Stata Corporation, College Station, Tex).RESULTS
Table I shows the association between reported alcohol intake
in the last 2 months of pregnancy and other maternal character-
istics among mothers for whom data were complete for at least
1 childhood atopic outcome. Mothers who reported drinking al-
cohol were more likely than mothers who reported never drink-
ing to be older, better educated, financially better off, and to
have taken paracetamol in pregnancy. In contrast, Table II
shows that the distribution of maternal ADH1B genotype
broadly does not vary according to maternal or offspring
characteristics.
TABLE I. Maternal characteristics by alcohol consumption in the last 2 months of pregnancy
Alcohol consumption (units/wk)
Never, no. (%) (N 5 3780) <1, no. (%) (N 5 2947) >_1, no. (%) (N 5 1475)
Mother’s age
<20 y 108 (3) 40 (1) 9 (1)
20-24 y 684 (18) 338 (11) 81 (5)
25-29 y 1564 (41) 1258 (43) 466 (32)
30-34 y 1077 (28) 983 (33) 630 (43)
>_35 y 347 (9) 328 (11) 289 (20)
Parity
0 1727 (46) 1284 (44) 619 (42)
1 1255 (33) 1095 (37) 527 (36)
>_2 716 (19) 510 (17) 299 (20)
Unknown 82 (2) 58 (2) 30 (2)
Maternal body mass index (kg/m2)
<18.5 171 (5) 109 (4) 54 (4)
18.5-24.99 2527 (67) 2108 (72) 1083 (73)
25-29.99 549 (15) 403 (14) 188 (13)
>_30 217 (6) 116 (4) 53 (4)
Unknown 316 (8) 211 (7) 97 (7)
Mother’s education level
<Ordinary level 1098 (29) 558 (19) 225 (15)
Ordinary level 1468 (39) 1089 (37) 387 (26)
>_Advanced level 1198 (32) 1292 (44) 861 (58)
Unknown 16 (<1) 8 (<1) 2 (<1)
Housing tenure
Owned/mortgaged 2915 (77) 2477 (84) 1261 (85)
Rented (public housing) 436 (12) 194 (7) 64 (4)
Rented (nonpublic housing) 257 (7) 152 (5) 99 (7)
Unknown/other 172 (5) 124 (4) 51 (3)
Financial difficulties
None 1425 (38) 1111 (38) 657 (45)
Some 1337 (35) 1144 (39) 499 (34)
Many 904 (24) 627 (21) 279 (19)
Unknown 114 (3) 65 (2) 40 (3)
Maternal asthma 246 (7) 175 (6) 81 (5)
Maternal eczema 422 (11) 358 (12) 179 (12)
Maternal rhinoconjunctivitis 665 (18) 585 (20) 292 (20)
Maternal migraine 577 (15) 398 (14) 188 (13)
Maternal anxiety score in pregnancy
0-4 1920 (51) 1514 (51) 757 (51)
5-9 1218 (32) 951 (32) 468 (32)
>_10 335 (9) 269 (9) 145 (10)
Unknown 307 (8) 213 (7) 105 (7)
Prenatal tobacco exposure (maximum in pregnancy)
Not exposed 1659 (44) 1436 (49) 695 (47)
Passive only 1267 (34) 967 (33) 472 (32)
Mother 1-9/d 283 (7) 225 (8) 145 (10)
Mother 10-19/d 395 (10) 211 (7) 101 (7)
Mother >_20/d 158 (4) 97 (3) 54 (4)
Unknown 18 (<1) 11 (<1) 8 (1)
Maternal paracetamol use in early pregnancy
Nonuser 1873 (50) 1260 (43) 600 (41)
User 1850 (49) 1654 (56) 857 (58)
Unknown 57 (2) 33 (1) 18 (1)
Maternal paracetamol use in late pregnancy
Nonuser 2219 (59) 1580 (54) 774 (52)
User 1447 (38) 1296 (44) 662 (45)
Unknown 114 (3) 71 (2) 39 (3)
Antibiotic use in late pregnancy 203 (5) 209 (7) 93 (6)
Maternal cold/flu in pregnancy 1478 (39) 1230 (42) 659 (45)
Maternal urinary infection in pregnancy 198 (5) 157 (5) 79 (5)
Maternal other infections in pregnancy 185 (5) 191 (6) 97 (7)
Includes all women with complete data for at least 1 childhood outcome (wheeze, eczema, hay fever, asthma, atopy, IgE) and self-reported alcohol consumption in the last
2 months of pregnancy.
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TABLE II. Maternal characteristics by maternal ADH1B
genotype
ADH1B genotype
GG, no. (%)
(N 5 5033)
AA/GA, no. (%)
(N 5 268)
Mother’s age
<20 y 86 (2) 3 (1)
20-24 y 671 (13) 37 (14)
25-29 y 2056 (41) 105 (39)
30-34 y 1657 (33) 93 (35)
>_35 y 563 (11) 30 (11)
Parity
0 2275 (45) 118 (44)
1 1750 (35) 92 (34)
>_2 909 (18) 52 (19)
Unknown 99 (2) 6 (2)
Maternal body mass index (kg/m2)
<18.5 208 (4) 14 (5)
18.5-24.99 3460 (69) 192 (72)
25-29.99 726 (14) 35 (13)
>_30 248 (5) 9 (3)
Unknown 391 (8) 18 (7)
Mother’s education level
<Ordinary level 1186 (24) 47 (18)
Ordinary level 1811 (36) 108 (40)
>_Advanced level 2023 (40) 113 (42)
Unknown 13 (<1) 0 (0)
Housing tenure
Owned/mortgaged 4093 (81) 222 (83)
Rented (public housing) 439 (9) 23 (9)
Rented (nonpublic housing) 297 (6) 16 (6)
Unknown/other 204 (4) 7 (3)
Financial difficulties
None 1957 (39) 104 (39)
Some 1816 (36) 93 (35)
Many 1127 (22) 66 (25)
Unknown 133 (3) 5 (2)
Maternal asthma 314 (6) 16 (6)
Maternal eczema 588 (12) 32 (12)
Maternal rhinoconjunctivitis 970 (19) 60 (22)
Maternal migraine 729 (14) 38 (14)
Maternal anxiety score in pregnancy
0-4 2664 (53) 133 (50)
5-9 1594 (32) 94 (35)
>_10 462 (9) 32 (12)
Unknown 313 (6) 9 (3)
Prenatal tobacco exposure
(maximum in pregnancy)
Not exposed 2285 (45) 133 (50)
Passive only 1700 (34) 94 (35)
Mother 1-9/d 405 (8) 13 (5)
Mother 10-19/d 429 (9) 19 (7)
Mother >_20/d 191 (4) 9 (3)
Unknown 23 (<1) 0 (0)
Maternal paracetamol use in early
pregnancy
Non user 2267 (45) 132 (49)
User 2691 (53) 133 (50)
Unknown 75 (1) 3 (1)
Maternal paracetamol use in late
pregnancy
Non user 2785 (55) 158 (59)
User 2113 (42) 104 (39)
Unknown 135 (3) 6 (2)
(Continued)
TABLE II. (Continued)
ADH1B genotype
GG, no. (%)
(N 5 5033)
AA/GA, no. (%)
(N 5 268)
Antibiotic use in late pregnancy 315 (6) 17 (6)
Maternal cold/flu in pregnancy 2060 (41) 105 (39)
Maternal urinary infection in
pregnancy
274 (5) 10 (4)
Maternal other infections in
pregnancy
292 (6) 12 (4)
Includes all women with complete data for at least 1 childhood outcome and ADH1B
genotype.
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shows the association between maternal ADH1B genotype and
reported maternal alcohol intake before and during pregnancy.
As expected, carriers of the A allele reported a lower intake
than those homozygous for the G allele both before and during
pregnancy, they were less likely to report binge drinking, and
they were more likely to report abstaining from alcohol during
pregnancy.
Table III shows the association between self-reported alcohol
consumption before and during pregnancy and childhood asthma
in persons with complete outcome data. Univariately, evidence
was weak for a lower prevalence of asthma in children of mothers
who reported consuming alcohol in the last 2 months of preg-
nancy. After controlling for confounders, evidence was still
weak for a lower prevalence of asthma in mothers who reported
consuming alcohol in the first 3 months (test for trend, P 5
.047) and last 2 months of pregnancy (test for trend, P 5 .074).
Table IV shows that, after controlling for confounders, reported
maternal alcohol intake in late pregnancy was negatively associ-
ated with hay fever in the offspring (test for trend, P 5 .024).
Tables E2-E5 (in the Online Repository at www.jacionline.org)
show the associations between reported alcohol consumption be-
fore and during pregnancy and childhood wheezing, eczema, at-
opy, and IgE. After controlling for confounders, maternal intake
was not associated with any outcome.
Table V shows the associations between maternal ADH1B gen-
otype and childhood atopic outcomes. Univariately, no associa-
tion was observed with any outcome. Similarly, among persons
with available PCAvariables derived from GWAS data, maternal
genotype was not associated with any outcome, either univari-
ately or after controlling for all potential confounders, including
the 10 PCA variables.
No evidence suggests that reported maternal alcohol intake in
late pregnancy (comparing 1 or more units per week with never)
modified the associations between maternal ADH1B genotype
and childhood asthma and other atopic outcomes (Table VI),
and no interactions were found with reported alcohol intake dur-
ing early pregnancy (data not shown).DISCUSSION
In this population-based birth cohort we have shown, using a
Mendelian randomization approach, that a maternal ADH1B
gene variant (rs1229984), as a proxy for prenatal alcohol expo-
sure, was unrelated to childhood atopic outcomes, suggesting that
alcohol consumption during pregnancy is unlikely to be an
important cause of these disorders. This conclusion is further
reinforced by the lack of evidence for an interaction between
TABLE III. Associations between self-reported alcohol
consumption before and during pregnancy and childhood
asthma
Univariate
analysis,
OR (95% CI)
Multivariate
analysis,
OR (95% CI)
Mother’s alcohol intake before
pregnancy (units/wk)
Never (n 5 446) 1.0 1.0
<1 (n 5 2860) 0.88 (0.66-1.18) 0.93 (0.69-1.26)
1-6 (n 5 3410) 0.85 (0.64-1.14) 0.92 (0.68-1.25)
>_7 (n 5 890) 0.81 (0.57-1.14) 0.84 (0.59-1.21)
Test for trend (N 5 7606) 0.95 (0.86-1.04)* 0.96 (0.87-1.05)*
P value .229 .383
Mother’s current alcohol
intake at 8 wk of
pregnancy (units/wk)
Never (n 5 4728) 1.0 1.0
1-2 (n 5 973) 0.97 (0.78-1.20) 0.96 (0.77-1.20)
3-4 (n 5 524) 1.06 (0.81-1.39) 1.03 (0.78-1.37)
>_5 (n 5 659) 1.02 (0.79-1.30) 0.93 (0.71-1.20)
Test for trend (N 5 6884) 1.00 (0.94-1.09)* 0.98 (0.91-1.06)*
P value .808 .667
Mother’s alcohol intake in
first 3 mo of pregnancy
(units/wk)
Never (n 5 3356) 1.0 1.0
<1 (n 5 3088) 0.96 (0.82-1.11) 0.91 (0.78-1.06)
>_1 (n 5 1148) 0.89 (0.72-1.09) 0.81 (0.65-1.00)
Test for trend (N 5 7592) 0.95 (0.86-1.04)* 0.90 (0.81-0.99)*
P value .262 .047
Mother’s alcohol intake
during last 2 mo of
pregnancy (units/wk)
Never (n 5 3410) 1.0 1.0
<1 (n 5 2668) 0.92 (0.79-1.08) 0.92 (0.78-1.08)
>_1 (n 5 1327) 0.83 (0.68-1.02) 0.83 (0.67-1.02)
Test for trend (N 5 7405) 0.91 (0.83-1.00)* 0.91 (0.82-1.01)*
P value .062 .074
Mother’s binge drinking
(days in previous month
at 18 wk of pregnancy)
Never (n 5 6358) 1.0 1.0
1-2 (n 5 630) 1.11 (0.87-1.42) 0.95 (0.74-1.23)
>_3 (n 5 516) 0.98 (0.75-1.30) 0.84 (0.63-1.12)
Test for trend (N 5 7504) 1.02 (0.90-1.15)* 0.92 (0.81-1.05)*
P value .783 .235
OR, Odds ratio.
*OR per category increase in exposure. Multivariate analysis of maternal alcohol
intake adjusts for all confounders listed in Methods section.
TABLE IV. Associations between self-reported alcohol
consumption before and during pregnancy and childhood hay
fever
Univariate
analysis,
OR (95% CI)
Multivariate
analysis.
OR (95% CI)
Mother’s alcohol intake before
pregnancy (units/wk)
Never (n 5 449) 1.0 1.0
<1 (n 5 2875) 1.28 (0.87-1.87) 1.27 (0.86-1.89)
1-6 (n 5 3428) 1.26 (0.87-1.84) 1.17 (0.79-1.73)
>_7 (n 5 903) 1.15 (0.74-1.77) 1.03 (0.66-1.62)
Test of trend (N 5 7655) 1.0 (0.90-1.11)* 0.96 (0.86-1.07)*
P value .944 .437
Mother’s current alcohol
intake at 8 wk of
pregnancy (units/wk)
Never (n 5 4753) 1.0 1.0
1-2 (n 5 977) 1.02 (0.81-1.30) 0.95 (0.74-1.22)
3-4 (n 5 530) 1.02 (0.74-1.39) 1.04 (0.75-1.44)
>_5 (n 5 670) 0.70 (0.51-0.97) 0.71 (0.50-0.99)
Test for trend (N 5 6930) 0.93 (0.85-1.01)* 0.93 (0.84-1.02)*
P value .095 .109
Mother’s alcohol intake in
first 3 mo of pregnancy
(units/wk)
Never (n 5 3370) 1.0 1.0
<1 (n 5 3100) 0.83 (0.70-0.99) 0.84 (0.70-1.01)
>_1 (n 5 1172) 0.88 (0.70-1.11) 0.91 (0.71-1.17)
Test for trend (N 5 7642) 0.91 (0.81-1.02)* 0.93 (0.82-1.04)*
P value .103 .203
Mother’s alcohol intake
during last 2 mo of
pregnancy (units/wk)
Never (n 5 3434) 1.0 1.0
<1 (n 5 2678) 0.92 (0.77-1.09) 0.85 (0.71-1.03)
>_1 (n 5 1346) 0.83 (0.66-1.05) 0.77 (0.60-0.99)
Test for trend (N 5 7458) 0.91 (0.82-1.02)* 0.87 (0.78-0.98)*
P value .101 .024
Mother’s binge drinking
(days in previous month
at 18 wk of pregnancy)
None (n 5 6396) 1.0 1.0
1-2 (n 5 633) 0.91 (0.68-1.23) 0.96 (0.71-1.31)
>_3 (n 5 523) 0.73 (0.51-1.04) 0.78 (0.54-1.13)
Test for trend (N 5 7552) 0.87 (0.74-1.02)* 0.90 (0.77-1.06)*
P value .079 .219
OR, Odds ratio.
*OR per category increase in exposure. Multivariate analysis of maternal alcohol
intake adjusts for all confounders listed in Methods section.
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such an interaction, with a weaker or absent effect of the gene in
mothers reporting no alcohol intake, would have been expected if
there was a causal effect of prenatal alcohol exposure.33 The lack
of evidence of association between maternal ADH1B genotype
and atopic outcomes in the offspring also suggests that maternal
consumption of alcohol before, or periconception, is unlikely to
influence childhood asthma and allergies; in ALSPAC the same
nonsynonymous variant of ADH1B is strongly associated with al-
cohol use just before, as well as during, pregnancy.28
Given the principles underpinning Mendelian randomiza-
tion,34,35 our genetic findings are much less likely to beconfounded by lifestyle or environmental factors than the weak
negative associations we observed between reported maternal al-
cohol intake in late pregnancy and risk of asthma and hay fever in
the offspring. Mothers who drank alcohol in pregnancy tended to
be older, better educated, and financially better off than mothers
who abstained. Although we controlled for a large number of so-
cioeconomic and other background characteristics in the analyses
of reported maternal drinking, the possibility of residual or un-
controlled confounding remains. Furthermore, the negative asso-
ciations between reported maternal intake and childhood asthma
and hay fever conflict with the few previous epidemiologic stud-
ies that have suggested a positive relation between prenatal
TABLE V. Associations between maternal ADH1B genotype and childhood atopic outcomes
Outcome by
ADH1B genotype No.
Univariate maternal
effect estimate* (95% CI)
No. of reduced
data sety
Univariate maternal
effect estimate* (95% CI)
Multivariate maternal
effect estimate* (95% CI)
Asthma
G:G 4524 1.0 3266 1.0 1.0
A:A/G:A 231 0.98 (0.66-1.47) 171 0.86 (0.53-1.41) 0.90 (0.54-1.51)
Total 4755 3437
P value .937 .571 .699
Wheezing
G:G 4575 1.0 3280 1.0 1.0
A:A/G:A 237 1.12 (0.75-1.67) 171 1.04 (0.64-1.68) 1.08 (0.65-1.79)
Total 4812 3451
P value .582 .867 .754
Eczema
G:G 4567 1.0 3295 1.0 1.0
A:A/G:A 234 1.01 (0.71-1.43) 170 1.07 (0.72-1.60) 1.14 (0.75-1.73)
Total 4801 3465
P value .961 .730 .539
Hay fever
G:G 4556 1.0 3248 1.0 1.0
A:A/G:A 236 1.11 (0.71-1.72) 171 1.12 (0.67-1.87) 1.15 (0.67-1.97)
Total 4792 3419
P value .653 .673 .616
Atopy
G:G 3571 1.0 2811 1.0 1.0
A:A/G:A 193 1.09 (0.77-1.55) 152 1.12 (0.76-1.65) 1.23 (0.82-1.84)
Total 3764 2963
P value .610 .571 .327
IgE
G:G 2852 1.0 2404 1.0 1.0
A:A/G:A 158 1.07 (0.82-1.40) 133 0.97 (0.72-1.30) 0.96 (0.72-1.30)
Total 3010 2537
P value .606 .815 .806
OR, Odds ratio.
*OR (geometric mean ratio for IgE analysis).
Data set reduced because of incomplete PCA variables derived from GWAS data.
J ALLERGY CLIN IMMUNOL
JANUARY 2014
230 SHAHEEN ET ALalcohol exposure and atopic outcomes.11-13 Although there is
some evidence for a protective effect of alcohol on allergic airway
inflammation and airway hyperresponsiveness in an adult mouse
model of allergic asthma,3 the mechanisms underlying such an ef-
fect and the relevance of these observations to the inception of
asthma after prenatal exposure in humans are unclear. In addition,
other animal data indicate detrimental effects of prenatal expo-
sure on fetal lung growth and development.4-6 The findings for
hay fever, if real, would be expected to be mediated through an
effect on atopy, yet we did not find similar negative associations
between reported intake and atopy or IgE. We therefore think it
is unlikely that prenatal alcohol exposure in pregnancy protects
against asthma and other atopic disease.
In ALSPAC, mothers carrying the minor A allele consumed
less alcohol during pregnancy. Previous in vitro data suggested
that carriers of this allele metabolize alcohol up to 100 times
faster than persons homozygous for the G allele36 and conse-
quently consume less alcohol to avoid the negative effects of
high acetaldehyde concentrations; this in turn would reduce expo-
sure of the fetus to alcohol, which readily crosses the placenta. Al-
though amore recent study has suggested that this variant makes a
minor contribution to the variation in alcohol metabolism
in vivo,37 lack of power because of the variant’s low frequency
in European populations is the most likely explanation for this.
The utility of ADH1B genotype as a Mendelian randomizationinstrument has been clearly demonstrated in relation to alcohol-
induced cancer.27,33Strengths and limitations
Our study has a number of strengths, including ALSPAC’s
population-based prospective design and rich data on maternal
reported alcohol use in pregnancy, potential confounders and
detailed phenotypic outcome measurements. In addition, few
other birth cohorts have maternal DNA available. Measurement
of maternal ADH1B genotype enabled us to use a Mendelian
randomization approach to investigate the relation between
prenatal alcohol exposure and atopic outcomes. In contrast,
most previous epidemiologic studies of the effects of maternal
alcohol use in pregnancy on offspring health have relied on
reported consumption, an approach which is highly susceptible
to bias and confounding. Although there was potential for associ-
ations with ADH1B genotype to be confounded by population
substructure, we reduced this possibility by excluding those
with reported non-white ethnicity and by performing sensitivity
analyses in which we controlled for PCA variables derived from
GWAS data.We acknowledge, however, that, given the lowminor
allele frequency for rs1229984, we lacked power to detect small
or modest effects of this variant, as indicated by the confidence in-
tervals around the effect estimates, and also power to detect
TABLE VI. Associations between maternal ADH1B genotype and childhood atopic outcomes stratified by reported alcohol intake
during the last 2 mo of pregnancy
Outcome by ADH1B genotype
Mother’s alcohol intake (units/wk) never Mother’s alcohol intake (units/wk) >_1
No. Adjusted estimate* (95% CI) No. Adjusted estimate* (95% CI)
Asthma
G:G 2001 1.0 2372 1.0
G:A/A:A 121 0.94 (0.53-1.68) 103 1.14 (0.62-2.10)
Total 4597
Wheezing
G:G 2024 1.0 2400 1.0
G:A/A:A 124 1.26 (0.72-2.19) 105 0.87 (0.43-1.73)
Total 4653
Eczema§
G:G 2018 1.0 2397 1.0
G:A/A:A 121 0.89 (0.52-1.52) 105 1.23 (0.75-2.02)
Total 4641
Hay feverk
G:G 2017 1.0 2388 1.0
G:A/A:A 124 0.98 (0.52-1.87) 104 1.23 (0.62-2.46)
Total 4633
Atopy{
G:G 1538 1.0 1894 1.0
G:A/A:A 102 1.29 (0.80-2.09) 83 1.12 (0.65-1.95)
Total 3617
IgE**
G:G 1191 1.0 1557 1.0
G:A/A:A 85 1.23 (0.85-1.78) 70 0.91 (0.61-1.36)
Total 2903
GMR, Geometric mean ratio.
*Estimates (OR [GMR for IgE analysis]) are adjusted for all confounders listed in Methods section.
P for interaction 5 .664.
P for interaction 5 .411.
§P for interaction 5 .384.
kP for interaction 5 .636.
{P for interaction 5 .710.
**P for interaction 5 .288.
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have not taken into account the ability of the fetus to metabolize
alcohol and hence the potential effect of gene variants in the child
on atopic outcomes. Nevertheless, we would argue that the
maternal ADH1B gene is likely to have a greater influence on
fetal alcohol exposure because it is so strongly associated with
maternal drinking behavior. As with any longitudinal study,
data were not complete on exposures, outcomes, and confounders
for the whole cohort. Therefore, we cannot rule out the possibility
that exclusion of children without complete information might
have biased our findings for reported alcohol intake; however,
importantly, it is unlikely that missing genotype data would
bias the main genetic results.Public health implications
In conclusion, with the use of a Mendelian randomization
approach, we have not found evidence to suggest that alcohol
consumption in pregnancy increases the risk of childhood atopic
disease. Nor did associations with reported intake suggest increased
risks. Nevertheless, because of other potential risks to the develop-
ing fetus of low-level alcohol consumption, pregnantwomen should
still heed current advice to abstain from consuming alcohol.38,39
We are extremely grateful to all the families who took part in this study, the
midwives for their help in recruiting them, and the whole ALSPAC team,which includes interviewers, computer and laboratory technicians, clerical
workers, research scientists, volunteers, managers, receptionists and nurses.
Clinical implications: Although pregnant women should be ad-
vised to abstain from alcohol, this study has reassuringly found
no evidence that alcohol exposure in utero increases the risk of
atopic disease in the offspring.REFERENCES
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TABLE E1. Association between maternal ADH1B genotype and reported maternal alcohol intake before and during pregnancy
ADH1B genotype
GG, No. (%) (N 5 5033) GA/AA, No. (%) (N 5 268)
Mother’s alcohol intake before pregnancy (units/wk)
Never 275 (5) 18 (7)
<1 1820 (36) 126 (47)
1-6 2273 (45) 102 (38)
>_7 599 (12) 20 (7)
Unknown 66 (1) 2 (1)
Mother’s current alcohol intake at 8 wk of pregnancy (units/wk)
Never 3074 (61) 197 (74)
1-2 686 (14) 30 (11)
3-4 342 (7) 17 (6)
>_5 454 (9) 9 (3)
Unknown 477 (9) 15 (6)
Mother’s alcohol intake in first 3 mo of pregnancy (units/wk)
Never 2130 (42) 138 (51)
<1 2035 (40) 99 (37)
>_1 795 (16) 27 (10)
Unknown 73 (1) 4 (1)
Mother’s alcohol intake during last 2 mo of pregnancy (units/wk)
Never 2211 (44) 143 (53)
<1 1722 (34) 81 (30)
>_1 898 (18) 34 (13)
Unknown 202 (4) 10 (4)
Mother’s binge drinking (days in previous month at 18 wk of pregnancy)
None 4164 (83) 237 (88)
1-2 441 (9) 14 (5)
>_3 351 (7) 13 (5)
Unknown 77 (2) 4 (1)
Includes all women with complete data for at least 1 childhood outcome and ADH1B genotype.
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TABLE E2. Associations between self-reported alcohol consumption before and during pregnancy and childhood wheezing
Univariate analysis, OR (95% CI) Multivariate analysis, OR (95% CI)
Mother’s alcohol intake before pregnancy (units/wk)
Never (n 5 452) 1.0 1.0
<1 (n 5 2888) 0.91 (0.66-1.24) 0.96 (0.69-1.32)
1-6 (n 5 3443) 0.88 (0.65-1.20) 0.92 (0.67-1.28)
>_7 (n 5 904) 0.96 (0.67-1.37) 0.95 (0.65-1.38)
Test for trend (N 5 7687) 0.99 (0.90-1.09) 0.98 (0.89-1.08)
P value .820 .703
Mother’s current alcohol intake at 8 wk of pregnancy (units/wk)
Never (n 5 4779) 1.0 1.0
1-2 (n 5 981) 1.08 (0.87-1.34) 1.03 (0.82-1.30)
3-4 (n 5 530) 1.12 (0.85-1.49) 1.08 (0.80-1.44)
>_5 (n 5 671) 1.05 (0.81-1.37) 0.95 (0.73-1.25)
Test for trend (N 5 6961) 1.03 (0.96-1.11)* 0.99 (0.92-1.08)*
P value .439 .957
Mother’s alcohol intake in first 3 mo of pregnancy (units/wk)
Never (n 5 3386) 1.0 1.0
<1 (n 5 3113) 1.04 (0.89-1.22) 0.98 (0.83-1.16)
>_1 (n 5 1174) 1.05 (0.85-1.30) 0.95 (0.76-1.19)
Test for trend (N 5 7673) 1.03 (0.93-1.14)* 0.98 (0.88-1.09)*
P value .575 .664
Mother’s alcohol intake during last 2 mo of pregnancy (units/wk)
Never (n 5 3445) 1.0 1.0
<1 (n 5 2696) 0.94 (0.80-1.11) 0.91 (0.76-1.08)
>_1 (n 5 1346) 0.98 (0.80-1.20) 0.92 (0.74-1.14)
Test for trend (N 5 7487) 0.98 (0.89-1.08)* 0.95 (0.85-1.06)*
P value .706 .335
Mother’s binge drinking (days in previous month at 18 wk of pregnancy)
None (n 5 6423) 1.0 1.0
1-2 (n 5 637) 0.97 (0.74-1.27) 0.85 (0.64-1.13)
>_3 (n 5 523) 1.12 (0.85-1.49) 0.99 (0.74-1.33)
Test for trend (N 5 7583) 1.04 (0.92-1.18)* 0.97 (0.84-1.11)*
P value .536 .619
OR, Odds ratio.
*OR per category increase in exposure. Multivariate analysis of maternal alcohol intake adjusts for all confounders listed in Methods section.
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TABLE E3. Associations between self-reported alcohol consumption before and during pregnancy and childhood eczema
Univariate analysis, OR (95% CI) Multivariate analysis, OR (95% CI)
Mother’s alcohol intake before pregnancy (units/wk)
Never (n 5 451) 1.0 1.0
<1 (n 5 2880) 1.08 (0.82-1.43) 1.03 (0.77-1.36)
1-6 (n 5 3438) 1.11 (0.85-1.46) 1.03 (0.78-1.37)
>_7 (n 5 904) 1.13 (0.83-1.54) 0.99 (0.72-1.38)
Test for trend (N 5 7673) 1.03 (0.95-1.12) 0.99 (0.92-1.09)
P value .438 .970
Mother’s current alcohol intake at 8 wk of pregnancy (units/wk)
Never (n 5 4766) 1.0 1.0
1-2 (n 5 980) 1.07 (0.89-1.29) 1.04 (0.86-1.26)
3-4 (n 5 530) 1.00 (0.79-1.28) 1.02 (0.79-1.32)
>_5 (n 5 670) 1.13 (0.91-1.40) 1.12 (0.90-1.40)
Test for trend (N 5 6946) 1.03 (0.97-1.10)* 1.03 (0.97-1.10)*
P value .303 .343
Mother’s alcohol intake in first 3 mo of pregnancy (units/wk)
Never (n 5 3379) 1.0 1.0
<1 (n 5 3107) 0.99 (0.87-1.13) 0.98 (0.86-1.13)
>_1 (n 5 1174) 1.06 (0.89-1.26) 1.08 (0.90-1.31)
Test for trend (N 5 7660) 1.02 (0.94-1.11)* 1.03 (0.94-1.12)*
P value .649 .554
Mother’s alcohol intake during last 2 mo of pregnancy (units/wk)
Never (n 5 3436) 1.0 1.0
<1 (n 5 2692) 1.03 (0.90-1.18) 0.98 (0.85-1.13)
>_1 (n 5 1346) 1.18 (0.99-1.39) 1.11 (0.93-1.33)
Test for trend (N 5 7474) 1.08 (0.99-1.17)* 1.04 (0.95-1.14)*
P value .077 .356
Mother’s binge drinking (days in previous month at 18 wk of pregnancy)
None (n 5 6411) 1.0 1.0
1-2 (n 5 637) 0.84 (0.66-1.05) 0.84 (0.66-1.07)
>_3 (n 5 522) 0.92 (0.72-1.18) 0.93 (0.72-1.20)
Test for trend (N 5 7570) 0.93 (0.83-1.04)* 0.94 (0.83-1.06)*
P value .227 .297
OR, Odds ratio.
*OR per category increase in exposure. Multivariate analysis of maternal alcohol intake adjusts for all confounders listed in Methods section.
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TABLE E4. Associations between self-reported alcohol consumption before and during pregnancy and childhood atopy
Univariate analysis, OR (95% CI) Multivariate analysis, OR (95% CI)
Mothers alcohol intake before pregnancy (units/wk)
Never (n 5 330) 1.0 1.0
<1 (n 5 2287) 1.12 (0.83-1.51) 1.09 (0.80-1.48)
1-6 (n 5 2717) 1.21 (0.90-1.62) 1.08 (0.80-1.47)
>_7 (n 5 725) 1.40 (1.01-1.94) 1.22 (0.87-1.73)
Test of trend (N 5 6059) 1.11 (1.02-1.20)* 1.05 (0.96-1.14)*
P value .014 .304
Mother’s current alcohol intake at 8 wk of pregnancy (units/wk)
Never (n 5 3713) 1.0 1.0
1-2 (n 5 780) 1.07 (0.89-1.29) 1.05 (0.86-1.27)
3-4 (n 5 427) 0.99 (0.78-1.27) 1.01 (0.78-1.30)
>_5 (n 5 525) 0.80 (0.63-1.01) 0.80 (0.63-1.03)
Test for trend (N 5 5445) 0.95 (0.89-1.02)* 0.95 (0.89-1.02)*
P value .167 .198
Mother’s alcohol intake in first 3 mo of pregnancy (units/wk)
Never (n 5 2614) 1.0 1.0
<1 (n 5 2502) 0.98 (0.86-1.12) 1.00 (0.87-1.15)
>_1 (n 5 939) 0.96 (0.80-1.15) 0.96 (0.79-1.17)
Test for trend (N 5 6055) 0.98 (0.90-1.07)* 0.99 (0.90-1.08)*
P value .639 .776
Mother’s alcohol intake during last 2 mo of pregnancy (units/wk)
Never (n 5 2615) 1.0 1.0
<1 (n 5 2133) 1.04 (0.90-1.19) 1.01 (0.87-1.16)
>_1 (n 5 1098) 0.99 (0.83-1.18) 0.92 (0.76-1.10)
Test for trend (N 5 5846) 1.0 (0.92-1.09)* 0.96 (0.88-1.05)*
P value .965 .429
Mother’s binge drinking (days in previous month at 18 wk of pregnancy)
None (n 5 5021) 1.0 1.0
1-2 (n 5 527) 0.96 (0.77-1.20) 0.99 (0.78-1.24)
>_3 (n 5 419) 0.80 (0.61-1.03) 0.86 (0.66-1.13)
Test for trend (N 5 5967) 0.91 (0.81-1.02)* 0.94 (0.83-1.06)*
P value .101 .319
OR, Odds ratio.
*OR per category increase in exposure. Multivariate analysis of maternal alcohol intake adjusts for all confounders listed in Methods section.
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TABLE E5. Associations between self-reported alcohol consumption before and during pregnancy and childhood IgE
Univariate analysis, GMR (95% CI) Multivariate analysis, GMR (95% CI)
Mother’s alcohol intake before pregnancy (units/wk)
Never (n 5 254) 1.0 1.0
<1 (n 5 1816) 1.07 (0.86-1.34) 1.11 (0.89-1.38)
1-6 (n 5 2179) 1.09 (0.88-1.35) 1.16 (0.93-1.44)
>_7 (n 5 554) 0.96 (0.75-1.23) 1.04 (0.81-1.34)
Test for trend (N 5 4803) 0.98 (0.92-1.05) 1.01 (0.95-1.08)
P value .602 .715
Mother’s current alcohol intake at 8 wk of pregnancy (units/wk)
Never (n 5 2920) 1.0 1.0
1-2 (n 5 649) 1.0 (0.87-1.16) 1.01 (0.87-1.16)
3-4 (n 5 345) 1.10 (0.91-1.32) 1.08 (0.90-1.30)
>_5 (n 5 436) 1.08 (0.91-1.27) 1.06 (0.89-1.25)
Test for trend (N 5 4350) 1.03 (0.98-1.08)* 1.02 (0.97-1.08)*
P value .268 .390
Mother’s alcohol intake in first 3 mo of pregnancy (units/wk)
Never (n 5 2066) 1.0 1.0
<1 (n 5 2002) 1.10 (0.99-1.22) 1.06 (0.96-1.18)
>_1 (n 5 731) 1.09 (0.95-1.26) 1.06 (0.92-1.22)
Test for trend (N 5 4799) 1.06 (0.99-1.13)* 1.04 (0.97-1.11)*
P value .095 .306
Mother’s alcohol intake during last 2 mo of pregnancy (units/wk)
Never (n 5 2033) 1.0 1.0
<1 (n 5 1730) 1.00 (0.90-1.12) 0.98 (0.88-1.10)
>_1 (n 5 897) 1.08 (0.95-1.23) 1.05 (0.92-1.20)
Test for trend (N 5 4660) 1.04 (0.97-1.10)* 1.02 (0.95-1.09)*
P value .283 .584
Mother’s binge drinking (days in previous month at 18 wk of pregnancy)
None (n 5 3980) 1.0 1.0
1-2 (n 5 426) 0.97 (0.82-1.15) 0.93 (0.79-1.10)
>_3 (n 5 323) 0.93 (0.77-1.12) 0.89 (0.73-1.07)
Test for trend (N 5 4729) 0.96 (0.89-1.05)* 0.94 (0.86-1.02)*
P value .403 .158
GMR, Geometric mean ratio.
*GMR per category increase in exposure. Multivariate analysis of maternal alcohol intake adjusts for all confounders listed in Methods section.
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